Chain Pharmacy

Compliance packaging, also called convenience packaging, is a good idea for both patients on many medications and for pharmacies. Here’s how to do it.

What pharmacists need to do-and what you should avoid.

After a bad 2017 season, pharmacies and the FDA are pushing the public to still get flu vaccines.

What one pharmacist says he wishes he’d prioritized sooner.

The opioid epidemic requires that all healthcare professionals-pharmacists included-re-examine how they approach pain patients.

Why one pharmacist thinks pharmacy education is being wasted.

Drug errors generally fall into one of four categories-here's how the experts say those errors can be eliminated. 

A study found that treating patients with rivaroxaban for 45 days after hospital discharge reducedthe rate of nonfatal blood clots, but had no effect on fatal blood clots. 

Tall man lettering is supposed to help reduce medication errors-but some say it doesn’t go far enough.

A retroactive study finds no connection between HPV and other vaccines and primary ovarian insufficiency.

There could be significant gains in adult vaccination rates if Insurers were required to cover vaccinations in pharmacies

Why pharmacists need to be paying attention to the Trinity II case and its consequences.

1.1 million Americans live with HIV-here’s how you can help.

Small Doses is back, bringing you the pharmacy news you need in a way that works for you.

Consumers have many options when it comes to their pharmaceutical purchases. Keep them coming back to you.

General Electric is being replaced by the drugstore/healthcare company.

Public health officials and activists call for action to reverse the rising U.S. maternal death rate. 

Scripps Translational Science Institute Partners with Walgreens/Blue Cross Blue Shield to enroll volunteers to use technology to study their own health.

At the NACDS annual meeting, a push for policies that allow pharmacies to optimize care.

If the past few weeks are any indication, pharmacy isn’t going to be the same for very long.

The CVS/Aetna deal won’t kill traditional pharmacy-it just shows that it’s already dead.

A Walgreens study found that pharmacist collaboration helps Hep C patients with better outcomes and cheaper co-pays.

Even if it doesn't happen, the deal says a lot about the current and future states of pharmacy.

Another large company pledges its support for helping to fight the opioid epidemic.

The chain has entered into a 5-year agreement with Anthem’s IngenioRx.